Evidence map›Paper›PMID 31016441›Full record

ArticleEuropean radiology2019

Patient radiation dose in percutaneous biliary interventions: recommendations for DRLs on the basis of a multicentre study.

Daniel Schmitz, Thomas Vogl, Nour-Eldin Abdelrehim Nour-Eldin, Boris Radeleff, Jens-Christian Kröger, Andreas H Mahnken, Harald Ittrich, Hans-Björn Gehl, Bernd Plessow, Joachim Böttcher and 17 more

Abstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in European radiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors.

Daniel SchmitzDepartment of Gastroenterology, Oncology and Diabetology, Theresienkrankenhaus and St. Hedwig Hospital, Academic Teaching Hospital of Heidelberg University, Bassermannstr.1, 68165, Mannheim, Germany. d.schmitz@theresienkrankenhaus.de.
Thomas VoglInstitute for Diagnostic and Interventional Radiology, University Hospital Frankfurt, Frankfurt, Germany.
Nour-Eldin Abdelrehim Nour-EldinInstitute for Diagnostic and Interventional Radiology, University Hospital Frankfurt, Frankfurt, Germany.
Boris RadeleffDepartment for Diagnostic and Interventional Radiology, Sana Municipal Hospital Hof, Hof, Germany.
Jens-Christian KrögerInstitute for Diagnostic and Interventional Radiology, University Medicine Rostock, Rostock, Germany.
Andreas H MahnkenInstitute for Diagnostic and Interventional Radiology, University Hospital Marburg, Marburg, Germany.
Harald IttrichClinic and Polyclinic for Diagnostic and Interventional Radiology and Nuclear Medicine, University Hospital Hamburg, Hamburg, Germany.
Hans-Björn GehlInstitute for Diagnostic Radiology, Municipal Hospital Bielefeld, Bielefeld, Germany.
Bernd PlessowRadiological Institute, University Medicine Greifswald, Greifswald, Germany.
Joachim BöttcherInstitute for Diagnostic and Interventional Radiology, SRH Wald-Klinikum Gera, Gera, Germany.
Josef TackeInstitute for Diagnostic and Interventional Radiology/Neuroradiology, Municipal Hospital Passau, Passau, Germany.
Markus WisplerCommunity Hospital Havelhöhe, Gastroenterology, Berlin, Germany.
Ulrich RosienMedical Clinic, Israelite Hospital Hamburg, Hamburg, Germany.
Wolfgang SchorrDepartment of Gastroenterology and Interventional Endoscopy, Barmherzige Brüder Hospital Regensburg, Regensburg, Germany.
Markus JoerdensDepartment of Gastroenterology, Oncology and Infectiology, University Hospital Düsseldorf, Düsseldorf, Germany.
Nicolas GlaserClinic for Internal Medicine II: Gastroenterology, Oncology, Endocrinology and Infectiology, University Hospital Freiburg, Freiburg, Germany.
Erik-Sebastian FuchsDepartment of Gastroenterology, Infectiology, Diabetology and Gastrointestinal Oncology (Medical Clinic C), Ludwigshafen Municipal Hospital, Ludwigshafen, Germany.
Andrea TalMedical Clinic I: Gastroenterology and Hepatology, Pneumology and Allergology, Endocrinology and Diabetology as Nutritional Medicine, University Hospital Frankfurt, Frankfurt, Germany.
Bettina Friesenhahn-OchsClinic for Internal Medicine II: Gastroenterology, Hepatology, Endocrinology, Diabetology and Nutritional Medicine, Saarland University Hospital, Homburg, Germany.
Thomas LeimbachClinic for Gastroenterology, Hepatology, Gastrointestinal Oncology, Municipal Hospital Bogenhausen Munich, Munich, Germany.
Lars HöpnerClinic for Gastrointestinal Diseases/Medical Clinic I, Municipal Clinic of Braunschweig, Braunschweig, Germany.
Marko WeberClinic for Internal Medicine IV: Gastroenterology, Hepatology, Infectiology, Interdisciplinary Endoscopy, University Hospital Jena, Jena, Germany.
Stefan GölderMedical Clinic III - Gastroenterology, Municipal Hospital Augsburg, Augsburg, Germany.
Michael BöhmigMedical Clinic I (Gastroenterology, Hepatology, Oncology, Infectiology), Agaplesion Markus Hospital Frankfurt, Frankfurt, Germany.
Svetlana HetjensDepartment of Medical Statistics and Biomathematics of Mannheim University Hospital, Heidelberg University-Hospital, Heidelberg, Germany.
Jochen RudiDepartment of Gastroenterology, Oncology and Diabetology, Theresienkrankenhaus and St. Hedwig Hospital, Academic Teaching Hospital of Heidelberg University, Bassermannstr.1, 68165, Mannheim, Germany.
Alexander SchegererDepartment for Radiation Protection and Health, Federal Office of Radiation Protection, Salzgitter, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivePercutaneous biliary interventions (PBIs) can be associated with a high patient radiation dose, which can be reduced when national diagnostic reference levels (DRLs) are kept in mind. The aim of this multicentre study was to investigate patient radiation exposure in different percutaneous biliary interventions, in order to recommend national DRLs.

methodsA questionnaire asking for the dose area product (DAP) and the fluoroscopy time (FT) in different PBIs with ultrasound- or fluoroscopy-guided bile duct punctures was sent to 200 advanced care hospitals. Recommended national DRLs are set at the 75th percentile of all DAPs.

resultsTwenty-three facilities (9 interventional radiology depts. and 14 gastroenterology depts.) returned the questionnaire (12%). Five hundred sixty-five PBIs with 19 different interventions were included in the analysis. DAPs (range 4-21,510 cGy·cm

conclusionsDAPs and FTs in percutaneous biliary interventions showed substantial variations depending on the centre and the type of PBI. PBI with US-guided bile duct puncture did not reduce DAP, when compared to PBI with fluoroscopy-guided bile duct puncture. National DRLs of 4300 cGy·cm KEY POINTS: • DAPs and FTs in percutaneous biliary interventions showed substantial variations depending on the centre and the type of PBI. • PBI with US-guided bile duct puncture did not reduce DAP when compared to PBI with fluoroscopy-guided bile duct puncture. • DRLs of 4300 cGy·cm

Indexed as

Biliary TractRadiation DosageRadiation ExposureRadiology, InterventionalAdultBiliary Tract Surgical ProceduresFemaleFluoroscopyGermanyHumansMaleRadiography, InterventionalReference ValuesRetrospective StudiesStentsBiliary systemInterventional radiographyInterventional ultrasoundMulticentre studyRadiation exposure

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.